Saturday 17 October 2026
Export PDEX’s income statement to Excel — free account
Pro-Dex, Inc.
PDEX Healthcare Medical Instruments & Supplies
Pro-Dex, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $77.5 million, up 16.5% from fiscal 2025. In the quarter to June 2026, revenue grew 16.7%, EPS grew 143.2%, free cash flow fell 79.0% and total debt rose 43.5%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.
58.26
1.76
−2.93%
Follow PDEX
| Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 | Jun '20 | Jun '19 | Jun '18 | Jun '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
6 | 6 | 6 | 6 | 3 | 2 | 7 | 5 | 6 | 6 |
P/E ratio |
13.84 | 15.81 | 29.13 | 10.27 | 12.70 | 19.93 | 11.37 | 13.42 | 17.37 | 4.88 |
Altman Z-Score |
7.38 | 6.63 | 4.65 | 4.44 | 3.66 | 5.73 | 6.36 | 6.42 | 8.69 | 7.91 |
P/S ratio |
2.44 | 2.15 | 1.19 | 1.48 | 1.38 | 3.05 | 2.00 | 2.05 | 1.26 | 1.13 |
Altman Z″-Score (non-manufacturers) |
8.66 | 8.16 | 7.06 | 6.64 | 5.66 | 5.83 | 7.69 | 7.90 | 11.83 | 9.67 |
P/FCF ratio |
28.08 | 0.00 | 12.33 | 15.31 | 0.00 | 0.00 | 15.89 | 28.79 | 12.96 | 9.56 |
Beneish M-Score |
(1.11) | (1.69) | (2.74) | (2.33) | (1.50) | (0.71) | (1.50) | (2.35) | (3.11) | (0.24) |
P/Operating CF |
(691.88) | (829.41) | 61.44 | 108.78 | (10.99) | 160.05 | 26.33 | 231.17 | 21.74 | 18.89 |
P/B ratio |
3.97 | 3.92 | 2.08 | 2.16 | 2.28 | 5.78 | 3.66 | 3.28 | 1.64 | 1.81 |
Price to Tangible BV |
4.67 | 3.92 | 2.08 | 2.16 | 2.29 | 5.83 | 3.69 | 3.30 | 1.66 | 1.83 |
EV/Sales |
2.49 | 2.19 | 1.21 | 1.59 | 1.59 | 3.22 | 1.84 | 1.85 | 0.94 | 0.91 |
EV/EBITDA |
13.39 | 12.20 | 7.78 | 11.02 | 11.22 | 23.30 | 8.37 | 9.22 | 5.28 | 5.87 |
EV/Operating CF |
26.62 | (86.55) | 10.43 | 13.37 | (78.68) | (58.98) | 12.94 | 15.09 | 6.79 | 6.18 |
EV/FCF |
28.67 | (49.16) | 12.46 | 16.40 | (26.47) | (11.80) | 14.59 | 25.94 | 9.59 | 7.69 |
Quick Ratio |
2.40 | 1.68 | 1.61 | 1.45 | 1.50 | 2.54 | 2.70 | 3.17 | 4.29 | 3.28 |
Current Ratio |
4.10 | 3.23 | 2.84 | 3.20 | 2.74 | 3.99 | 4.34 | 4.88 | 6.72 | 4.76 |
Net Debt/EBITDA |
0.27 | 0.17 | 0.08 | 0.73 | 1.46 | 1.24 | (0.74) | (1.01) | (1.86) | (1.43) |
Debt/Assets |
17.80% | 15.11% | 14.36% | 17.20% | 20.88% | 28.61% | 10.55% | 15.42% | 0.03% | 0.37% |
Debt/Equity |
0.28 | 0.25 | 0.24 | 0.28 | 0.40 | 0.57 | 0.17 | 0.23 | 0.00 | 0.00 |
Asset Turnover |
1.14 | 1.17 | 1.03 | 0.91 | 0.94 | 1.06 | 1.23 | 1.20 | 1.24 | 1.60 |
Operating CF/Net income |
0.53 | (0.19) | 2.93 | 0.77 | (0.19) | (0.34) | 0.81 | 0.80 | 1.91 | 0.64 |
Capex/Depreciation |
(0.34) | (1.00) | (0.84) | (1.12) | (2.04) | (11.30) | (0.96) | (3.13) | (0.57) | (0.95) |
Interest Coverage |
16.00 | 12.89 | 12.85 | 10.81 | 11.04 | 12.86 | 29.94 | 22.72 | 341.71 | 228.08 |
| 32.43% | 26.60% | 6.81% | 24.81% | 20.09% | 31.52% | 33.89% | 24.20% | 10.46% | 45.02% | |
| 20.14% | 15.80% | 4.08% | 14.02% | 10.23% | 17.27% | 21.58% | 18.26% | 8.94% | 36.98% | |
ROIC |
15.75% | 17.25% | 14.21% | 9.89% | 9.40% | 10.63% | 33.05% | 27.19% | 15.14% | 19.33% |
Return on Tangible Assets |
26.47% | 20.46% | 6.09% | 21.68% | 14.75% | 21.26% | 30.36% | 21.49% | 10.41% | 46.00% |
Average Days of Receivables |
102.73 | 95.86 | 94.14 | 78.82 | 133.56 | 104.93 | 54.02 | 55.08 | 48.01 | 58.85 |
Research and Development Expense of Revenue |
4.31% | 5.46% | 5.92% | 6.08% | 7.09% | 11.53% | 6.65% | 6.93% | 8.43% | 5.58% |
Selling, General and Administrative Expense of Revenue |
10.31% | 7.79% | 7.78% | 9.08% | 11.88% | 12.27% | 10.81% | 10.70% | 11.77% | 14.19% |
Intangible Assets out of Total Assets |
0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
Share Based Compensation of Revenue |
0.89% | 0.83% | 1.12% | 1.66% | 3.03% | 2.37% | 0.82% | 0.14% | 0.86% | 0.01% |
Graham Net Nets |
0.14 | 0.16 | 0.23 | 0.16 | 0.13 | 0.04 | 0.15 | 0.22 | 0.48 | 0.39 |
Graham Number |
37.49 | 26.30 | 11.18 | 19.24 | 14.06 | 13.51 | 13.11 | 9.51 | 5.86 | 9.81 |
Earnings Yield |
7.22% | 6.32% | 3.43% | 9.74% | 7.87% | 5.02% | 8.80% | 7.45% | 5.76% | 20.49% |
Free Cash Flow Yield |
3.56% | (2.06%) | 8.11% | 6.53% | (4.34%) | (8.95%) | 6.29% | 3.47% | 7.71% | 10.46% |
Revenue per Share |
24.04 | 20.25 | 15.39 | 12.91 | 11.56 | 10.02 | 8.91 | 6.48 | 5.22 | 5.43 |
Operating CF per Share |
2.24 | (0.51) | 1.78 | 1.53 | (0.23) | (0.55) | 1.26 | 0.79 | 0.72 | 0.80 |
Capex per Share |
(0.15) | (0.38) | (0.28) | (0.27) | (0.46) | (2.19) | (0.14) | (0.33) | (0.21) | (0.16) |
Free Cash Flow per Share |
2.10 | (0.89) | 1.50 | 1.26 | (0.69) | (2.73) | 1.12 | 0.46 | 0.51 | 0.64 |
Cash per Share |
2.90 | 2.18 | 1.96 | 1.14 | 0.44 | 1.32 | 2.30 | 2.26 | 1.72 | 1.22 |
Shareholders Equity per Share |
14.77 | 11.14 | 8.82 | 8.85 | 6.99 | 5.29 | 4.87 | 4.06 | 4.01 | 3.39 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
14.77 | 11.14 | 8.82 | 8.85 | 6.99 | 5.29 | 4.87 | 4.06 | 4.01 | 3.39 |
Free Cash Flow |
6.76 | (2.93) | 5.24 | 4.49 | (2.52) | (10.38) | 4.39 | 1.94 | 2.19 | 2.60 |
Working Capital |
40.27 | 32.67 | 23.72 | 21.30 | 19.81 | 18.74 | 17.45 | 16.58 | 13.82 | 9.70 |
Capital Expenditures |
(0.48) | (1.25) | (0.98) | (0.97) | (1.67) | (8.31) | (0.56) | (1.39) | (0.90) | (0.63) |
Net Current Asset Value |
26.37 | 22.74 | 15.00 | 10.75 | 7.51 | 4.78 | 10.61 | 12.33 | 13.59 | 9.64 |
EV/EBIT |
14.84 | 13.62 | 9.05 | 12.68 | 13.01 | 27.08 | 9.06 | 10.04 | 8.78 | 7.30 |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.02 | 0.04 | 0.22 | 0.02 | 0.05 | 0.04 | 0.03 |
Price to Operating Income |
14.54 | 13.42 | 8.95 | 11.84 | 11.32 | 25.64 | 9.86 | 11.15 | 11.88 | 9.08 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.12 | 0.11 | 0.10 | 0.08 | 0.07 | 0.07 | 0.22 | 0.16 | 0.90 | 0.49 |
Cash ROIC |
9.62% | (5.52%) | 11.58% | 10.07% | (6.75%) | (28.34%) | 14.00% | 6.37% | 8.88% | 13.91% |
Accounts Receivable Turnover |
3.95 | 4.24 | 4.52 | 3.64 | 3.20 | 4.73 | 7.53 | 7.70 | 6.92 | 8.61 |
Accounts Payable Turnover |
11.99 | 10.32 | 11.60 | 11.07 | 9.56 | 11.50 | 10.95 | 11.30 | 12.95 | 14.76 |
Inventory Turnover |
2.44 | 2.51 | 2.50 | 2.31 | 2.74 | 2.93 | 3.00 | 3.27 | 3.88 | 4.58 |
Average Days of Payables |
29.23 | 35.77 | 41.92 | 24.75 | 47.49 | 34.15 | 33.06 | 41.89 | 27.22 | 28.67 |
Days of Inventory on Hand |
147.19 | 172.20 | 141.84 | 177.00 | 160.07 | 125.93 | 138.62 | 130.94 | 110.41 | 76.28 |
Average Receivables |
19.66 | 15.69 | 11.92 | 12.67 | 13.16 | 8.04 | 4.63 | 3.53 | 3.25 | 2.55 |
Average Payables |
4.44 | 4.56 | 3.39 | 3.01 | 3.02 | 2.13 | 1.98 | 1.54 | 1.12 | 1.00 |
Average Inventory |
21.84 | 18.74 | 15.72 | 14.42 | 10.56 | 8.34 | 7.24 | 5.32 | 3.74 | 3.22 |
Average Assets |
67.85 | 56.83 | 52.15 | 50.46 | 44.70 | 35.72 | 28.32 | 22.72 | 18.13 | 13.75 |
Average Common Equity |
42.13 | 33.75 | 31.23 | 28.51 | 22.76 | 19.57 | 18.04 | 17.14 | 15.49 | 11.29 |
Columns are period end dates